48 related articles for article (PubMed ID: 10579803)
21. Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.
Griffin G; Atkinson PJ; Showalter VM; Martin BR; Abood ME
J Pharmacol Exp Ther; 1998 May; 285(2):553-60. PubMed ID: 9580597
[TBL] [Abstract][Full Text] [Related]
22. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells.
Waksman Y; Olson JM; Carlisle SJ; Cabral GA
J Pharmacol Exp Ther; 1999 Mar; 288(3):1357-66. PubMed ID: 10027878
[TBL] [Abstract][Full Text] [Related]
23. Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats.
Ding Y; Qiu Y; Jing L; Thorn DA; Zhang Y; Li JX
Pharmacol Res Perspect; 2014 Dec; 2(6):e00069. PubMed ID: 25431655
[TBL] [Abstract][Full Text] [Related]
24. Motor-like Tics are Mediated by CB
Gorberg V; Borisov V; Greig IR; Pertwee RG; McCaffery P; Anavi-Goffer S
Mol Neurobiol; 2022 Aug; 59(8):5070-5083. PubMed ID: 35666403
[TBL] [Abstract][Full Text] [Related]
25. Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats.
Achterberg EJM; van Swieten MMH; Driel NV; Trezza V; Vanderschuren LJMJ
Pharmacol Res; 2016 Aug; 110():151-158. PubMed ID: 27154553
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety.
Gray JM; Vecchiarelli HA; Morena M; Lee TT; Hermanson DJ; Kim AB; McLaughlin RJ; Hassan KI; Kühne C; Wotjak CT; Deussing JM; Patel S; Hill MN
J Neurosci; 2015 Mar; 35(9):3879-92. PubMed ID: 25740517
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid receptor antagonism disrupts the reconsolidation of social reward-related memories in rats.
Achterberg EJ; Trezza V; Vanderschuren LJ
Behav Pharmacol; 2014 Jun; 25(3):216-25. PubMed ID: 24776489
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the cannabinoid CB1 receptor in modulation of dopamine output in the prefrontal cortex associated with food restriction in rats.
Dazzi L; Talani G; Biggio F; Utzeri C; Lallai V; Licheri V; Lutzu S; Mostallino MC; Secci PP; Biggio G; Sanna E
PLoS One; 2014; 9(3):e92224. PubMed ID: 24632810
[TBL] [Abstract][Full Text] [Related]
29. Altered Mesolimbic Dopamine System in THC Dependence.
Spiga S; Lintas A; Diana M
Curr Neuropharmacol; 2011 Mar; 9(1):200-4. PubMed ID: 21886590
[TBL] [Abstract][Full Text] [Related]
30. delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.
Wise LE; Varvel SA; Selley DE; Wiebelhaus JM; Long KA; Middleton LS; Sim-Selley LJ; Lichtman AH
Psychopharmacology (Berl); 2011 Oct; 217(4):485-94. PubMed ID: 21559804
[TBL] [Abstract][Full Text] [Related]
31. CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
Schlosburg JE; O'Neal ST; Conrad DH; Lichtman AH
Psychopharmacology (Berl); 2011 Aug; 216(3):323-31. PubMed ID: 21340468
[TBL] [Abstract][Full Text] [Related]
32. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.
Sink KS; Segovia KN; Sink J; Randall PA; Collins LE; Correa M; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
Eur Neuropsychopharmacol; 2010 Feb; 20(2):112-22. PubMed ID: 20015619
[TBL] [Abstract][Full Text] [Related]
33. Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).
van Diepen H; Schlicker E; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2008 Oct; 378(4):345-69. PubMed ID: 18654765
[TBL] [Abstract][Full Text] [Related]
34. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
[TBL] [Abstract][Full Text] [Related]
35. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH
Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
[TBL] [Abstract][Full Text] [Related]
36. In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments.
Rubino T; Viganò D; Zagato E; Sala M; Parolaro D
Synapse; 2000 Jan; 35(1):8-14. PubMed ID: 10579803
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.
Rubino T; Patrini G; Massi P; Fuzio D; Viganò D; Giagnoni G; Parolaro D
J Pharmacol Exp Ther; 1998 May; 285(2):813-9. PubMed ID: 9580631
[TBL] [Abstract][Full Text] [Related]
38. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940.
Rubino T; Viganò D; Massi P; Parolaro D
J Neurochem; 2000 Nov; 75(5):2080-6. PubMed ID: 11032897
[TBL] [Abstract][Full Text] [Related]
39. Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study.
Freedland CS; Whitlow CT; Smith HR; Porrino LJ
Brain Res; 2003 Feb; 962(1-2):169-79. PubMed ID: 12543468
[TBL] [Abstract][Full Text] [Related]
40. SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists.
Costa B; Colleoni M
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1103-8. PubMed ID: 11189200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
